Stay updated on Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, signaling an incremental platform/template update. This change appears to be a backend or UI refinement rather than a modification to the study data or page content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page's revision indicator was updated from v3.6.4 to v3.6.5, signaling a minor update to the page’s version history without changes to the study content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a newer version of the page. No substantive study information appears to have changed.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing Revision: v3.6.2. This indicates a small site update that does not alter the study content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a small update to the page version.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now shows recruitment is closed ('No longer looking for participants') and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision note (Revision: v3.6.0). A formatting tweak updates the Intervention/Treatment label and removes the older Revision: v3.5.5 entry.SummaryDifference0.4%

Stay in the know with updates to Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page.